Date

Herbal medicinal product: Lupuli flosArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of hop strobile.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing hop strobile.
  • Herbal medicines containing these hop strobile preparations are usually available as herbal tea to be drunk or in liquid or solid forms to be taken by mouth.
  • Hop strobile preparations may also be found in combination with other herbal substances in some herbal medicines.

Herbal medicinal product: Lini semenArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Herbal medicinal product: Lini semenArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Lini semenArray, C: ongoing call for scientific data

Herbal medicinal product: Avenae fructusArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of oat grain.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing oat grain.
  • Herbal medicines containing these oat grain preparations are usually used in semi-solid forms to be applied to the skin and in solid forms as bath additives.
  • Oat grain preparations may also be found in combination with other herbal substances in some herbal medicines.

Herbal medicinal product: Avenae herbaArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of oat herb.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing oat herb.
  • Herbal medicines containing these oat herb preparations are usually available in solid or liquid forms to be taken by mouth or as herbal tea to be drunk.
  • Oat herb preparations may also be found in combination with other herbal substances in some herbal medicines.

Herbal medicinal product: Boldi foliumArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of boldo leaf.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing boldo leaf.
  • Herbal medicines containing these boldo leaf preparations are usually available as herbal tea to be drunk and in solid forms to be taken by mouth.
  • Boldo leaf preparations may also be found in combination with other herbal substances in some herbal medicines.

Herbal medicinal product: Calendulae flosArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Herbal medicinal product: Calendulae flosArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Calendulae flosArray, C: ongoing call for scientific data

Herbal medicinal product: Gentianae radixArray, C: ongoing call for scientific data

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of gentian root.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing gentian root.
  • Herbal medicines containing these gentian root preparations are usually available as herbal tea to be drunk and in solid or liquid forms to be taken by mouth.
  • Gentian root preparations may also be found in combination with other herbal substances in some herbal medicines.

Herbal medicinal product: Silybi mariani fructusArray, F: Assessment finalised

Retrieved on: 
Tuesday, March 12, 2024

Herbal medicinal product: Silybi mariani fructusArray, F: Assessment finalised

Key Points: 


Herbal medicinal product: Silybi mariani fructusArray, F: Assessment finalised

Herbal medicinal product: Symphyti radixArray, F: Assessment finalised

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of comfrey root.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing comfrey root.
  • Herbal medicines containing this comfrey root preparation are available in semi-solid forms (such as creams or ointments) to be applied to the skin.
  • Comfrey root - Summary for the public
    Key facts
    - Latin name
    - Symphyti radix
    - English common name
    - Comfrey Root
    - Botanical name
    Symphytum officinale L.
    - Therapeutic area
    - Pain and inflammation
    - Status
    - F: Assessment finalised
    - Date added to the inventory
    - Date added to priority list
    - Outcome of European assessment
    - European Union herbal monograph

New Fortress Energy Inc. Announces Increase to Previously Announced Cash Tender Offer for its 6.750% Senior Secured Notes due 2025

Retrieved on: 
Tuesday, March 5, 2024

For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.

Key Points: 
  • For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.
  • If the Tender Offer is not fully subscribed as of the Early Tender Date, Holders who validly tender Notes after the Early Tender Date may be subject to proration, whereas Holders who validly tender Notes at or prior to the Early Tender Date will not be subject to proration.
  • The Total Consideration includes an early tender payment (the “Early Tender Payment”) of $30.00 for each $1,000 principal amount of the Notes, which Early Tender Payment is in addition to the Tender Offer Consideration.
  • Holders must decide whether to tender Notes, and if tendering, the amount of Notes to tender.